Possible distinct pathogenesis in low responder myasthenia gravis: association of soluble interleukin-2 receptor with acetylcholine receptor antibody titre or abnormal thymus.
作者信息
Hayashi M, Kida K, Yoshinaga J
出版信息
J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):207-8. doi: 10.1136/jnnp.61.2.207.
Abstract
摘要
相似文献
1
Possible distinct pathogenesis in low responder myasthenia gravis: association of soluble interleukin-2 receptor with acetylcholine receptor antibody titre or abnormal thymus.低反应性重症肌无力可能存在的不同发病机制：可溶性白细胞介素-2受体与乙酰胆碱受体抗体滴度或胸腺异常的关联。
J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):207-8. doi: 10.1136/jnnp.61.2.207.
2
Ocular Myasthenia Gravis Associated With Thymic Amyloidosis.与胸腺淀粉样变性相关的眼肌型重症肌无力
J Neuroophthalmol. 2016 Mar;36(1):50-2. doi: 10.1097/WNO.0000000000000241.
3
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.抗肌肉特异性激酶阳性和阴性重症肌无力患者的胸腺变化
Neurology. 2005 Feb 8;64(3):536-8. doi: 10.1212/01.WNL.0000150587.71497.B6.
4
Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.重症肌无力中乙酰胆碱受体抗体水平与胸腺病理学的相关性：综述
J Clin Neuromuscul Dis. 2013 Jun;14(4):209-17. doi: 10.1097/CND.0b013e31828a0090.
5
[Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
No To Shinkei. 1980 Sep;32(9):909-19.
6
Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?相关自身抗体是否会影响胸腺切除术后重症肌无力的预后？
Autoimmunity. 2015;48(8):552-5. doi: 10.3109/08916934.2015.1064400. Epub 2015 Jul 30.
7
[Clinical significance of quantitative antibodies measurement in blood serum by interaction with muscle acetylcholine receptor domain in myasthenia patients].[通过与重症肌无力患者肌肉乙酰胆碱受体结构域相互作用对血清中抗体进行定量测定的临床意义]
Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(2):34-7.
8
Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.重症肌无力中的胸腺细胞可选择性增强自体血淋巴细胞产生抗乙酰胆碱受体抗体的能力。
N Engl J Med. 1981 Nov 26;305(22):1313-8. doi: 10.1056/NEJM198111263052203.
9
[Myasthenia gravis: physiopathologic and clinical study].[重症肌无力：病理生理与临床研究]
Rev Prat. 1979 Jun 21;29(35):2773-86.
10
Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.人重症肌无力中抗烟碱型乙酰胆碱受体抗体的酶联免疫吸附测定
Ann Neurol. 1984 Feb;15(2):195-200. doi: 10.1002/ana.410150214.
引用本文的文献
1
Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background.儿童期重症肌无力的病理生理学：神经肌肉接头异常、自身免疫及其背景
Pathophysiology. 2023 Dec 2;30(4):599-617. doi: 10.3390/pathophysiology30040043.
本文引用的文献
1
Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum.
J Neuroimmunol. 1993 Oct;48(1):33-6. doi: 10.1016/0165-5728(93)90055-4.
2
Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.重症肌无力的异质性：眼肌型和全身型的HLA表型及自身抗体反应
Ann Neurol. 1987 Mar;21(3):274-8. doi: 10.1002/ana.410210309.
3
Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians.
Neurology. 1987 Dec;37(12):1854-7. doi: 10.1212/wnl.37.12.1854.
4
Soluble interleukin-2 receptor in childhood non-Hodgkin's lymphoma.儿童非霍奇金淋巴瘤中的可溶性白细胞介素-2受体
Blood. 1988 Apr;71(4):1172-4.
5
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.无乙酰胆碱受体抗体的重症肌无力：一种独特的疾病实体。
Lancet. 1986 Jan 18;1(8473):116-9. doi: 10.1016/s0140-6736(86)92259-2.
6
Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis.
Clin Immunol Immunopathol. 1992 Feb;62(2):190-8. doi: 10.1016/0090-1229(92)90072-v.
Zotero 插件